Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03355
Species: Homo sapiens
Position : chr15:55288865-55289335
Year: 2023
Title: SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: pancreatic ductal adenocarcinoma
PMID:  37641131
MONDO: MONDO:0005184
Tissue: pancreas
Tissue Ontology ID: UBERON:0001264
Cell Source: MIA PaCa-2
CVCL ID: CVCL_0428
Cell Type: pancreatic carcinoma epithelial cell
Experiment Type: Enhancer activity assay; Chromatin architectural-protein binding assay; Endogenous functional perturbation assay
High Throughput Method: Public chromatin-conformation data; SMC3 ChIP-seq integration; TCGA methylation/expression analysis
Low Throughput Method: SMC3 ChIP-qPCR; luciferase reporter assay; combined CRISPR/Cas9 enhancer targeting; RT-qPCR; Western blot
About Target Gene
Target gene : RAB27A
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 2 found
Enhancer ID Position Tissue Cell Disease
E_03354 chr15:55288865-55289335 pancreas pancreatic carcinoma epithelial cell pancreatic ductal adenocarcinoma
E_03356 chr15:55288865-55289335 pancreas pancreatic carcinoma epithelial cell pancreatic ductal adenocarcinoma
Expression of Target Genes for the Enhancer